Campaign Urges Reporting of Illegal E-Cigarette Sales to Minors

Regulations by 2FIRSTS.ai
Dec.20.2023
Campaign Urges Reporting of Illegal E-Cigarette Sales to Minors
UKVIA launches a new initiative urging retailers, consumers, and the public to report sales of e-cigarettes to minors.

According to a report by UK media outlet Betterretailing on December 19th, the UK Vaping Industry Association (UKVIA) has recently launched a new initiative urging retailers, consumers, and the public to report outlets that sell e-cigarettes to minors, as well as non-compliant retailers and wholesalers. This campaign, named "Keep Vaping Vigilant," has received support from trade standards agencies, ACS, and the wider retail industry, with the aim of addressing the issue of youth e-cigarette use.

 

The "Stay Vigilant on e-cigarette" campaign, according to UKVIA, aims at mobilizing compliant retailers. A new study from compliance firm Arcus Compliance reveals that local law enforcement teams require greater resources in addressing the issues of youth access to e-cigarettes and illegal product sales.

 

James Lowman, CEO of the Association of Convenience Stores (ACS), has commented that the sales of e-cigarettes to minors remain excessively high, warranting renewed attention to the issue. Notably, retailers selling e-cigarettes to children are also often found to be selling illegal e-cigarette products. Responsible retailers are eager to witness rigorous enforcement standards, and the introduction of a reporting mechanism through this campaign will aid in identifying irresponsible enterprises, allowing officials from the Traffic Standards Bureau to concentrate their resources on addressing these establishments.

 

Kate Pike, Chief Officer of the Trading Standards Institute (CTSI), has expressed full support for this campaign, hoping that it will effectively encourage people to report cases where retailers are selling counterfeit or non-compliant e-cigarettes to children. Pike acknowledges that most retailers make efforts to only sell to adults and welcomes any intelligence that can help enforce the law against offenders.

 

The UKVIA has successfully launched a new online platform where consumers can report retailers and wholesalers suspected of engaging in violations. Users are required to provide the name and location of the store in question, along with detailed information on the alleged illicit activities.

 

John Dunne, director of UKVIA, added:

 

Individuals under the age of 18, or those who do not smoke, should not be using these products. It is certain that unscrupulous retailers are placing e-cigarettes in the hands of minors and stocking illegal merchandise, which is completely unacceptable.

 

He reiterated his hope that consumers, compliant retailers, parents, teachers, and the general public stay vigilant and proactively report any suspicious illegal activities.

 

The UKVIA also provides a range of downloadable materials for responsible retailers to display in-store, in order to encourage the general public to play a key role in combating illegal retailers and wholesalers. All promotional materials for the "Keep e-cigarette vigilant" campaign include a QR code that links back to an online reporting facility.

 

Deng En added, "The only way to prevent teenagers from using e-cigarettes is to find the root of the problem - those merchants who intend to break the law and evade accountability. We need as much assistance as possible from those who sincerely earn a living from selling e-cigarettes and from the public who care about the welfare of children.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22